期刊文献+

新型通用血浆的制备与临床应用进展 被引量:2

Progress in preparation of new universal plasma and its clinical application
下载PDF
导出
摘要 新型通用血浆是用于所有ABO血型的血浆,它不但打破"同型输血"的观念,简化了输血前的检测过程,更重要的是灭活了已知病毒,降低输血风险。本文就这种通用血浆的研制和临床应用进展作一综述。
出处 《军医进修学院学报》 CAS 2011年第4期406-408,共3页 Academic Journal of Pla Postgraduate Medical School
基金 军队"十一五"课题基金项目(09MA019)~~
  • 相关文献

参考文献17

  • 1Stainsby D. Haemovigilance in the United Kingdom and Europe [ J ] . Hematol J, 2004, 5 Suppl 3 : S175-S178.
  • 2Olsson ML, Clausen H. Modifying the red cell surface : towards an ABO-universal blood supply[ J ]. Br J Haematol, 2008,140( 1 ): 3-12.
  • 3张印则,李伟,单小燕,兰炯采,章扬培,张志欣.通用血小板的研究[J].免疫学杂志,2005,21(4):309-312. 被引量:4
  • 4Solheim BG, Chetty R, Flesland O. Indications for use and costeffectiveness of pathogen-reduced ABO-universal plasma [ J ] . Curr Opin Hematol, 2008, 15 ( 6 ) : 612-617.
  • 5Solheim BG. Pathogen reduction of blood components [ J ] . Transfus Apher Sci, 2008, 39 ( 1 ) : 75-82.
  • 6Solheim BG, Granov DA, Juravlev VA, et al. Universal fresh-frozen plasma (Uniplas) : an exploratory study in adult patients undergoing elective liver resection [ J ] . Vox Sang, 2005, 89 ( 1 ) : 19-26.
  • 7Hellstern P, Haubeh H. Manufacture and composition of fresh frozen plasma and virus-inactivated therapeutic plasma preparations : correlation between composition and therapeutic efficacy [ J ] . Thromb Res, 2002, 107 Suppl 1 : S3-S8.
  • 8Heger A, Svae TE, Neisser-Svae A, et al. Biochemical quality of the pharmaceutically licensed plasma OctaplasLG after implementation of a novel prion protein (PrPSc) removal technology and reduction of the solvent/detergent (S/D) process time [ J ] . Vox Sang, 2009, 97 ( 3 ) : 219-225.
  • 9Neisser-Svae A, Bailey A, Gregori L, et al. Prion removal effect of a specific affinity ligand introduced into the manufacturing process of the pharmaceutical quality solvent/detergent (S/D)-treated plasma OctaplasLG [ J ] . Vox Sang, 2009, 97 ( 3 ) : 226-233.
  • 10AuBuchon JP, Herschel L, Roger J, et al. Efficacy of apheresis platelets treated with riboflavin and ultraviolet light for pathogen reduction [ J ] . Transfusion, 2005, 45 ( 8 ) : 1335-1341.

二级参考文献9

  • 1Saito S, Ota M, Komatsu Y, et al. Serologic analysis of three cases of neonatal alloimmume thrombocytopenia associated with HLA antibodies [J]. Transfusion, 2003, 43 (7):908 - 917.
  • 2Juji T, Watanabe Y, Ishikawa Y, et al. Human platelet alloantigen (HPA)-5a/b mismatch decreases disease-free survival in unrelated bone marrow transplantation [ J]. Tissue Antigens, 1999, 54 (3): 229 - 234.
  • 3Glenn E. Rodey MD. HLA Beyond Tears: Introduction to human histocompatibility [ M]. 2nd ed. New York, USA: De NoVo Inc. Durango, CO, 2000: 67- 73.
  • 4Leach JK, Hinman A, O'Rear EA. Investigation of deformability, viscosity, and aggregation of mPEG-modified erythrocytes [J]. Biomed Sci Instrum, 2002, 38:333 - 338.
  • 5Scott MD, Chen AM. Beyond the red cell: pegylation of other blood cells and tissues [ J ]. Transfus Clin Biol, 2004,11 (1): 40-46.
  • 6Mozos E, Herraez P, Perez J, et al. Cutaneous lesions in experimental acute and subacute African swine fever: an immunohistopathological and ultrastructural study [ J]. Dtsch Tierarztl Wochenschr, 2003, 110 (4): 150- 154.
  • 7Bennet W, Sundberg B, Elgue G, et al. A new in vitro model for the study of pig-to-human vascular hyperacute rejection [J]. Xenotransplantation, 2001, 8 (3): 176- 184.
  • 8Ozmen L, Ekdahl KN, Elgue G, et al. Inhibition of thrombin abrogates the instant blood-mediated inflammatory reaction triggered by isolated human islets: possible application of the thrombin inhibitor melagatran in clinical islet transplantation [J]. Diabetes, 2002, 51 (6): 1 779 - 1 784.
  • 9张印则,李伟,周华友,夏荣,兰炯采,章扬培,张志欣.淋巴细胞表面HLA-I类抗原的阻断[J].中国实验血液学杂志,2003,11(6):622-624. 被引量:1

共引文献3

同被引文献6

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部